EcoSynthetix Inc

EcoSynthetix operates with a strong liquidity position, as evidenced by a current ratio of 20.06, indicating that the company holds significantly more current assets than current liabilities. The company's price-to-book ratio of 4.9 suggests that the market values the company at nearly five times its book value, which is a relatively high valuation. However, the company's negative operating income of $1,222,760 and net income of -$683,890 indicate that it is currently not generating positive earnings.

In terms of profitability, EcoSynthetix is underperforming relative to industry norms. The company's return on equity (ROE) of -1.72% and return on assets (ROA) of -1.64% are both negative, suggesting that the company is not effectively utilizing its equity or assets to generate returns. These metrics are below the typical performance of companies in the specialty chemicals industry, which often have positive ROE and ROA figures.

The company's revenue is concentrated in a single business segment, as disclosed in its financial reports, with no material geographic diversification reported. This lack of diversification could expose the company to higher risks if demand in its primary market segment or region declines.

Looking at the company's growth trajectory, there is no clear indication of revenue growth in the current fiscal year. The company's free cash flow is negative at -$705,790, and capital expenditures of -$412,720 suggest that the company is investing in its operations. However, without a corresponding increase in revenue or profitability, these investments may not yield immediate returns.

The risk assessment for EcoSynthetix indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.01 is very low, suggesting that it is not heavily leveraged. However, the company's net cash position is negative after subtracting total debt, which could be a concern for its short-term liquidity. There are no significant dilution risks identified, and the company has not made any recent equity issuances that would suggest a need for additional capital.

Recent events, as disclosed in the company's filings, include ongoing research and development activities aimed at expanding its product portfolio. The company has also been exploring strategic partnerships to enhance its market reach. These developments could potentially impact the company's future performance and growth prospects.

Revenue grew 12.2% year-over-year to $20.8 million, demonstrating top-line expansion momentum in the latest fiscal period.

The company maintains a very low debt-to-equity ratio of 0.01, indicating minimal leverage relative to its book value.

The company faces high credit risk and medium liquidity risk, signaling potential financial stability concerns for investors.

Cash conversion is negative at -0.6, falling into the bottom quartile and indicating poor ability to generate cash from operations.

Revenue $19.0M, +4,8% YoY; Operating income +10,4% YoY.

• ▍Revenue $19.0M, +4,8% YoY
• ▍Operating income +10,4% YoY
• ▍Net income +25,3% YoY
• ▍Free cash flow +35,0% YoY
• ▍Net margin -12.5%

Revenue $18.2M; Operating income -$3.2M.

• ▍Revenue $18.2M
• ▍Operating income -$3.2M
• ▍Net margin -17.5%